HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Seidman Selected Research

Michael Seidman Research Topics

Disease

3Tinnitus
06/2019 - 03/2002
2Fanconi Anemia (Fanconi's Anemia)
04/2016 - 01/2016
2Bloom Syndrome
01/2016 - 09/2010
2Vertigo (Positional Vertigo)
02/2012 - 03/2002
1Vasculitis (Vasculitides)
12/2021
1Giant Cell Arteritis (Horton Disease)
12/2021
1Marfan Syndrome (Marfan's Syndrome)
01/2019
1Emphysema
01/2019
1Sensorineural Hearing Loss
10/2018
1Exostoses
01/2018
1Neurofibromatosis 2 (Neurofibromatosis Type II)
12/2017
1Immunoglobulin G4-Related Disease
04/2017
1Lymphadenopathy
04/2017
1Eosinophilia
04/2017
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
04/2017
1Rare Diseases (Rare Disease)
04/2017
1Granuloma
12/2012
1Paralysis (Palsy)
02/2012
1Pathologic Complete Response
01/2011
1Hypersensitivity (Allergy)
08/2009
1Ataxia Telangiectasia (Louis Bar Syndrome)
08/2009
1Chromosomal Instability (Chromosome Stability)
08/2009
1Werner Syndrome (Werner's Syndrome)
01/2006
1Noise-Induced Hearing Loss (Acoustic Trauma)
11/2003
1Hearing Loss (Hearing Impairment)
11/2003
1Meniere Disease (Menieres Disease)
03/2002
1Leukemia
01/2002

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
04/2016 - 01/2006
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2006
1Peroxidase (Myeloperoxidase)IBA
12/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2021
1Fibrillin-1IBA
01/2019
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2019
1Sildenafil Citrate (Viagra)FDA Link
01/2019
1Rituximab (Mabthera)FDA Link
04/2017
1Immunoglobulin E (IgE)IBA
04/2017
1Immunoglobulin G (IgG)IBA
04/2017
1Immunoglobulins (Immunoglobulin)IBA
04/2017
1SteroidsIBA
04/2017
1EnzymesIBA
04/2016
1CholesterolIBA
12/2012
1Thymidine Monophosphate (TMP)IBA
02/2012
1DNA-Binding Proteins (DNA Binding Protein)IBA
08/2009
1Indicators and Reagents (Reagents)IBA
08/2009
1AntioxidantsIBA
11/2003
1ResveratrolIBA
11/2003
1Gentamicins (Gentamicin)FDA LinkGeneric
03/2002
1Organophosphonates (Phosphonates)IBA
01/2002
1C2-mycophenolic adenine dinucleotideIBA
01/2002
1C4-mycophenolic adenine dinucleotideIBA
01/2002
1AdenineFDA LinkGeneric
01/2002

Therapy/Procedure

4Therapeutics
06/2019 - 03/2002
1Transcranial Magnetic Stimulation
06/2019
1Deep Brain Stimulation
06/2019
1Electrodes (Electrode)
06/2019
1Vagus Nerve Stimulation
06/2019
1Craniotomy
01/2018
1Decompression
12/2017
1Salvage Therapy
12/2017
1Drug Therapy (Chemotherapy)
01/2011